Thomas A. Langan

4.0k total citations
51 papers, 3.3k citations indexed

About

Thomas A. Langan is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Thomas A. Langan has authored 51 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in Thomas A. Langan's work include DNA and Nucleic Acid Chemistry (8 papers), Genomics and Chromatin Dynamics (8 papers) and Metabolism and Genetic Disorders (5 papers). Thomas A. Langan is often cited by papers focused on DNA and Nucleic Acid Chemistry (8 papers), Genomics and Chromatin Dynamics (8 papers) and Metabolism and Genetic Disorders (5 papers). Thomas A. Langan collaborates with scholars based in United States, United Kingdom and Sweden. Thomas A. Langan's co-authors include Robert A. Sclafani, Miriam H. Meisler, M.S. Nissen, Raymond Reeves, Irene E. Schauer, N. Weiner, E. Morton Bradbury, Philip Cohen, Philip R Vulliet and H.R. Matthews and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Thomas A. Langan

50 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas A. Langan United States 29 2.4k 638 552 387 270 51 3.3k
Michael Gschwendt Germany 33 3.4k 1.4× 535 0.8× 514 0.9× 384 1.0× 432 1.6× 90 4.6k
I A Rose United States 28 3.2k 1.3× 688 1.1× 859 1.6× 196 0.5× 309 1.1× 49 3.8k
V. Kinzel Germany 31 2.6k 1.1× 571 0.9× 433 0.8× 190 0.5× 260 1.0× 126 3.5k
J. Gordon Foulkes United Kingdom 27 2.0k 0.8× 428 0.7× 266 0.5× 254 0.7× 99 0.4× 37 2.9k
ISAMI TAKAHASHI Japan 19 3.2k 1.3× 519 0.8× 605 1.1× 175 0.5× 333 1.2× 29 4.6k
K L Luskey United States 26 2.7k 1.1× 528 0.8× 264 0.5× 321 0.8× 332 1.2× 38 3.9k
Woon Ki Paik United States 41 4.3k 1.8× 474 0.7× 327 0.6× 164 0.4× 201 0.7× 177 5.4k
Lawrence M. Ballas United States 24 2.2k 0.9× 327 0.5× 243 0.4× 389 1.0× 228 0.8× 37 3.5k
N. K. Tonks United States 22 4.7k 1.9× 669 1.0× 680 1.2× 173 0.4× 274 1.0× 25 5.5k
Karen L. Leach United States 31 2.5k 1.0× 378 0.6× 340 0.6× 427 1.1× 182 0.7× 54 3.6k

Countries citing papers authored by Thomas A. Langan

Since Specialization
Citations

This map shows the geographic impact of Thomas A. Langan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Langan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Langan more than expected).

Fields of papers citing papers by Thomas A. Langan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Langan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Langan. The network helps show where Thomas A. Langan may publish in the future.

Co-authorship network of co-authors of Thomas A. Langan

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Langan. A scholar is included among the top collaborators of Thomas A. Langan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Langan. Thomas A. Langan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Todd, Maria C., Thomas A. Langan, & Robert A. Sclafani. (2017). Doxycycline-Regulated p16MTS1 Expression Suppresses the Anchorage-Independence and Tumorigenicity of Breast Cancer Cell Lines that Lack Endogenous p16. Journal of Cancer. 8(2). 190–198. 6 indexed citations
2.
Todd, Maria C., Robert A. Sclafani, & Thomas A. Langan. (2000). Ovarian cancer cells that coexpress endogenous Rb and p16 are insensitive to overexpression of functional p16 protein. Oncogene. 19(2). 258–264. 29 indexed citations
3.
Shellman, Yiqun G., et al.. (1999). Identification and characterization of individual cyclin-dependent kinase complexes fromSaccharomyces cerevisiae. Yeast. 15(4). 295–309. 2 indexed citations
4.
Ferrigno, Paul Ko, Thomas A. Langan, & Philip Cohen. (1993). Protein phosphatase 2A1 is the major enzyme in vertebrate cell extracts that dephosphorylates several physiological substrates for cyclin-dependent protein kinases.. Molecular Biology of the Cell. 4(7). 669–677. 97 indexed citations
5.
Magno, Michael G., et al.. (1993). Chronic stimulation enhances extramyocardial collateral blood flow after a cardiomyoplasty. The Annals of Thoracic Surgery. 56(5). 1045–1053. 9 indexed citations
6.
Nissen, M.S., Thomas A. Langan, & Raymond Reeves. (1991). Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein.. Journal of Biological Chemistry. 266(30). 19945–19952. 121 indexed citations
7.
Sola, María M., Thomas A. Langan, & Philip Cohen. (1991). p34cdc2 phosphorylation sites in histone H1 are dephosphorylated by protein phosphatase 2A1. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1094(2). 211–216. 69 indexed citations
8.
Langan, Thomas A., Jean Gautier, Manfred J. Lohka, et al.. (1989). Mammalian Growth-Associated H1 Histone Kinase: a Homolog of cdc2+/CDC28 Protein Kinases Controlling Mitotic Entry in Yeast and Frog Cells. Molecular and Cellular Biology. 9(9). 3860–3868. 71 indexed citations
9.
Yanagihara, Nobuyuki, A. William Tank, Thomas A. Langan, & Norman Weiner. (1986). Enhanced Phosphorylation of Tyrosine Hydroxylase at More Than One Site Is Induced by 56 mM K+ in Rat Pheochromocytoma PC 12 Cells in Culture. Journal of Neurochemistry. 46(2). 562–568. 15 indexed citations
10.
Chambers, Timothy C., Thomas A. Langan, Harry R. Matthews, & E. Morton Bradbury. (1983). H1 histone kinases from nuclei of Physarum polycephalum. Biochemistry. 22(1). 30–37. 22 indexed citations
11.
Langan, Thomas A., et al.. (1981). Sites in histone H1 selectively phosphorylated by guanosine 3‘:5‘-monophosphate-dependent protein kinase.. Journal of Biological Chemistry. 256(2). 994–1001. 22 indexed citations
12.
Leichtling, Ben H., et al.. (1980). Coordinate regulation of adenylate cyclase, protein kinase, and specific enzyme synthesis by cholera toxin in hormonally unresponsive hepatoma cells. Archives of Biochemistry and Biophysics. 205(2). 595–605. 8 indexed citations
13.
Langan, Thomas A.. (1980). Malignant transformation and protein phosphorylation. Nature. 286(5771). 329–330. 9 indexed citations
14.
Langan, Thomas A.. (1978). Chapter 13. Methods for the Assessment of Site-Specific Histone Phosphorylation. Methods in cell biology. 19. 127–142. 65 indexed citations
15.
Gilson, Étienne, Thomas A. Langan, & Armand Maurer. (1977). Historia Filozofii Wspóllzesnej Od Hegla Do Czasów Najnowszych. Talanta. 38(9). 977–9.
16.
Rattle, H. W. E., et al.. (1977). Studies on the Role and Mode of Operation of the Very‐Lysine‐Rich Histones in Eukaryote Chromatin. European Journal of Biochemistry. 81(3). 499–505. 21 indexed citations
17.
Langan, Thomas A., et al.. (1976). Advance of mitosis by histone phosphokinase. Experimental Cell Research. 97(2). 418–425. 72 indexed citations
18.
Langan, Thomas A., S C Rall, & R. David Cole. (1971). Variation in Primary Structure at a Phosphorylation Site in Lysine-rich Histones. Journal of Biological Chemistry. 246(6). 1942–1944. 55 indexed citations
19.
Langan, Thomas A.. (1962). Existential Phenomenology. The Modern Schoolman. 39(4). 398–400. 1 indexed citations
20.
Langan, Thomas A., et al.. (1960). A New Method for Degrading Glucose to Xylose and Galactose to Arabinose.. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry. 14. 1118–1123. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Gschwendt Breakdown of academic impact, for papers by I A Rose Breakdown of academic impact, for papers by V. Kinzel Breakdown of academic impact, for papers by J. Gordon Foulkes Breakdown of academic impact, for papers by ISAMI TAKAHASHI Breakdown of academic impact, for papers by K L Luskey Breakdown of academic impact, for papers by Woon Ki Paik Breakdown of academic impact, for papers by Lawrence M. Ballas Breakdown of academic impact, for papers by N. K. Tonks Breakdown of academic impact, for papers by Karen L. Leach
Rankless by CCL
2026